Adrestia

Adrestia Therapeutics is an England-based biotechnology company that develops and markets synthetic rescue therapies to treat cancer and genetic disorders.

Business Model:

Revenue: $2.4M

Employees: 2-10

Rankings

Detailed Adrestia Information

Geographic Data

Adrestia headquarters map

Address: Babraham Research Campus, Babraham

City: Cambridge

State: england

Zip: CB22 3AT

Country: GB

Financial Info

Stage:

series a

Raised Last:

$233M

Raised Total:

$233M

Metrics

7,604,080Website Global Rank

483Website Monthly Traffic

Twitter Followers

Description

Adrestia Therapeutics is an England-based biotechnology company that develops and markets synthetic rescue therapies to treat cancer and genetic disorders.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2020 Series A -
12/2020 Series A 2 $232.6M GlaxoSmithKline
Ahren Innovation Capital
Ahren Innovation Capital
GlaxoSmithKline
9/2018 Seed Round 1 - Ahren Innovation Capital
Ahren Innovation Capital
12/2020 Series A - GSK
AHREN
GSK
AHREN
9/2018 Seed Round 1 - Ahren Innovation Capital
Ahren Innovation Capital
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research